Introduction
Recognition of a foreign substance initiates adaptive immunity, thereby generating Ag-specific T cells and Abs. The immune system can recognize autologous molecules as well as exogenous ones, but the immune reaction against an autologous Ag can cause a deleterious condition, the autoimmune response. The thymus has a crucial role in the prevention of autoimmune responses by educating a T-cell precursor, the thymocyte, to become unresponsive to autologous Ags. This process, called intrathymic education, consists of two processes, negative selection and differentiation of naturally occurring Treg (nTreg) cells. Negative selection eliminates thymocytes, which can recognize autologous Ags with high affinity, while nTreg can inhibit the effecter T (Teff) cell response to autologous Ags in an Ag-specific manner.
The mode of immune response can differ depending on the dose of Ag, the route of administration, and the presence of adjuvant. Subcutaneous or dermal injection of a protein emulsified in adjuvant can activate T cells [1] , whereas oral exposure to an Ag can induce tolerance [2] . Moreover, an intravenous injection of a high-dose Ag can induce Ag-specific immune tolerance [3] [4] [5] and can prevent autoimmune diseases in mice such as type 1 diabetes mellitus [6] or EAE [4] . Although intrathymic education is generally vital to induce immune tolerance, the role of the thymus in immune tolerance induced by an intravenous injection of a high-dose Ag needs further clarification.
IL-2 is one of the most important cytokines for Treg-cell development and survival [7] . Moreover, Webster et. al. [8] observed that in vivo administration of IL-2 immune complexes (ICs) can induce a marked increase in Treg cells in many organs, including the liver and gut as well as the spleen and LNs, with a modest increase in Treg cells in the thymus. Furthermore, pre-treatment with IL-2 ICs rendered mice resistant to induction of EAE and induced tolerance to fully MHC-incompatible pancreatic transplants [8] . Hamano 4 We previously demonstrated that thymic CD11c DCs (cDCs) are preferentially localized in an interlobular vascular-rich region and that they can selectively capture blood-circulating Ag and induce Ag-specific Treg-cell generation, thereby inducing immune tolerance in the thymus [9, 10] . We therefore postulated that the combined intravenous injection of an Ag and IL-2 ICs could expand Ag-specific Treg cells with a capacity to migrate to the Ag-containing site, thereby reducing Ag-specific immune responses. In order to prove this assumption, we examined the effects of combined intravenous injection of OVA and IL-2 ICs on an OVA-induced DTH reaction in the skin. We provide here definitive evidence indicating that the treatment generated Ag-specific Treg cells in thymus which could migrate preferentially to the DTH site in a CCR2-dependent manner, thereby dampening the DTH reaction. Hamano 5 
Results

Ag-specific Treg cells preferentially migrate to an Ag-containing site.
We first examined whether Ag-specific Treg cells could migrate to the Ag injection site.
In order to address this point, we repeated intravenous OVA injection to DO11.10 mice twice before OVA administration into air pouch ( Figure 1A ). This resulted in the rapid appearance of KJ1-26 Figure 1D ). Furthermore, the in vivo primed Treg cells, in which CFSE signal was diluted by the cell division, mainly accumulated in the air pouch ( Figure 1D ). Consequently, Ag-specific Treg cells can migrate to the site containing the Ag.
Intravenously administered Ag induces intrathymic Treg cells and their migration into the periphery
We previously demonstrated that an intravenous injection of an Ag can induce differentiation of Ag-specific Treg cells in the thymus [10] . Untreated thymus contained a small number of both KJ1-26 Thus, Ag-specific Treg cells, which were generated in the thymus, could migrate into the antigen site more efficiently than peripherally-induced Treg cells.
Ag-specific Treg cells migrate to the air pouch in a CCR2-dependent manner
The selective migration of Ag-specific Treg cells prompted us to investigate the contribution of chemokines, which can exhibit chemotactic activities on a selected set of leukocytes with their receptors [11] [12] [13] . Flow cytometry (FCM) analysis demonstrated an enhanced expression of several chemokine receptors including CCR2, CCR4, CCR5, and CXCR4 on Ag-specific Treg cells infiltrating in Ag-injected air pouch, compared with Teff cells ( Figure 3A ). Of particular interest is that most Ag-specific Treg cells in the OVA-injected air pouch expressed CCR2, and that the expression level was higher than that in the draining LN (dLN). These observations Hamano 7 suggested the involvement of the ligands for these receptors in the migration of Ag-specific Foxp3 + Treg cells into the air pouch. The administration of OVA into the air pouch consistently induced increases in the contents of CCL2, the ligand for CCR2, CCL17 and CCL22, the ligands for CCR4, and CCL5 (RANTES), the ligand for CCR5 (Supporting Information Figure 4 ), but not CXCL12, the ligand for CXCR4 (data not shown). In order to prove the roles of these chemokines, we blocked the axes of these chemokines. Consistent with the previous report [14, 15] Figure 3C ). This proved that CCR2 expression on Treg cells is necessary for their migration to Ags. Thus, the expression of CCR2 can contribute to the preferential Ag-specific Treg-cell migration into the Ag-injected site. 
Discussion
The administration of a high-dose Ag can induce immune tolerance by utilizing several mechanisms including depletion of Teff cells [4] , induction of T-cell apoptosis in peripheral blood and thymus [5] , suppression of Ig production [17] , and expansion of Treg cells [18] . Here, we determined that an intravenous injection of a high-dose of Ag could efficiently expand Ag-specific Treg cells in a thymus-dependent manner and that the expansion could be further augmented by the additional administration of IL-2 ICs.
Moreover, the expanded Ag-specific Treg cells preferentially migrated to the local injection site of Ag in a CCR2-dependent manner to prevent immune response-mediated DTH reactions.
We previously demonstrated that thymic CD11c Ags from bloodstream [9] to induce Ag-specific Treg-cell generation [10] . Also under the present conditions, we observed that Ag-specific Treg cells appeared in the circulation after their transient intrathymic expansion. Evidence is accumulating to indicate that Treg cells can be generated in the spleen and LNs as well as the thymus.
However, the removal of thymus but not spleen markedly reduced the increase in Ag-specific Treg-cell numbers in peripheral blood. Helios, a member of Ikaros transcription factor family, was once reported to be a marker of thymus-derived Treg cells. Intravenous Ag injection induced Helios expression on Ag-specific Treg cells in the thymus but not spleen. Thereafter, Ag-specific Treg cells in circulation started to express Helios. Several lines of evidence questioned the validity of Helios as a specific marker of thymus-derived Treg cells [19, 20] . However, intravenous Ag injection efficiently increased the Ag-specific Treg cells, which were generated in the thymus and to a lesser extent, ones converted in the periphery in the Ag containing site. Thus, it is probable that an intravenous Ag injection could induce Treg-cell generation in the thymus, although Treg-cell conversion from other T-cell populations in the periphery Hamano 12 can also contribute to a certain extent.
Treg cells can be classified into two populations with distinct roles in immune tolerance, nTreg and induced Treg (iTreg) cells [21] . nTreg cells are generated in the thymus and can regulate mainly Th1 mediated-immune responses. On the contrary, iTreg cells are generated in the periphery outside the thymus and can control Th2 mediated-response in mucosal tolerance [22] . We demonstrated that an intravenous Ag injection can induce Ag-specific Treg cells in the thymus. Thus, the intrathymically generated Treg cells can suppress DTH reaction, a typical Th1-mediated immune response upon reaching local Ag injection site. Several immunosuppressive maneuvers were developed by using iTreg cells, which were either expanded ex vivo [23] or differentiated in vitro [24] . On the contrary, we provided the first definitive evidence to indicate the immunosuppressive potential of intrathymic differentiated Ag-specific Treg cells, which are expanded independently of AIRE [25] . Currently used immune-suppressive agents can inhibit immune reaction broadly and in an Ag-nonspecific manner. Thus, the use of Ag-specific Treg cells can be more effective and less harmful due to their selectivity. Moreover, the selectivity can be Hamano 13 further augmented by Ag-specific activation of Treg cells to exert their Ag-specific suppressive function in vivo [18] . Furthermore, once activated with an Ag, Ag-specific Treg cells can suppress additional immune reactions against other unrelated Ags in the organ exhibiting the specific Ag, resulting in organ-specific immune suppression against a broad range of Ags [30, 31] . We demonstrate that Ag-IL-2 ICs treatment can efficiently expand and activate Ag-specific Treg cells with the capacity to migrate to the organ containing a specific Ag. Thus, the present approach may be effective for organ-specific immune diseases, if pathogenic Ags or organ-specific Ags are definitively identified as in the case of contact dermatitis and GVHD.
It is of interest that the expanded Ag-specific Treg cells preferentially migrated to the Ag injection site in the peripheral tissue, both in air pouch model and DTH reaction.
Treg cells can migrate into various sites such as the tumor tissues, infected site and transplanted organs [15, [32] [33] [34] , to suppress immune response to the tumor, infected tissues, or transplanted organs [27, 35] . Leukocyte migration is controlled by several factors and among them, chemokines have a crucial role. Leukocytes can migrate in response to the interaction between chemokine(s) expressed in the local site and the chemokine receptor(s) expressed by leukocytes [36] [37] [38] . Several lines of evidence indicate that Treg migration into the peripheral tissue is regulated by CD103, CCR2, CCR4 and CCR5 expression [15, 16, 34, 39, 40] . In particular, it is broadly known that CCR4 signaling plays an important role in Treg cells migration [15] . We demonstrated that most Ag-specific Treg cells expressed CCR2 as well as CCR4 and CCR5, and that Ag-injected air pouch contained abundant CCL2, the ligand for CCR2. These results suggest that CCR2 also have crucial roles in Treg cells migration. This notion is further supported by our present observation that blocking CCR2-mediated signaling 
Materials and Methods
Mice
Female Balb/c mice were obtained from Charles River Japan (Yokohama, Japan) and designated as WT mice. DO11.10 mice expressing a Tg TCR that recognizes the OVA323-339 peptide in the context of I-A d were maintained as heterozygotes.
DO11.10/CCR2
-/-mice were generated by mating DO11.10 and CCR2-deficient mice as previously described [9] . All mice were maintained in the animal facility of the Kanazawa University under specific pathogen-free conditions. All animal experiments were approved and performed according to the Guideline for the Care and Use of Laboratory Animals of Kanazawa University
Reagents and Abs
Rat anti-mouse DO11. 
Air pouch model (Figure 1A)
Subcutaneous air pouches were prepared as described with some modifications [41] .
Briefly, 5 ml of air was subcutaneously injected to dorsal surface of WT or DO11.10 mice. 2 mg of OVA dissolved in 200 μL of PBS was injected intravenously twice, one and two days after the air injection. 3 ml of air was additionally injected into the air pouch on Day 3. On Day 4, 100 μg of OVA in 1 ml of PBS was injected into the air Hamano 16 pouch. At the indicated time points after the last OVA injection into the air pouch, the cells in the air pouch were recovered by washing the air pouch with 1 ml of cold PBS.
The obtained fluid samples were centrifuged to obtain the supernatants and the cell suspensions. The supernatants were used for the determination of chemokines by ELISA while the cell suspensions were used for cell surface marker analysis by FCM after the determination of the cell number. In some experiments, lymphocytes were collected from LNs of DO11.10 or DO11.10/CCR2 -/-mice, which were untreated or intravenously administered with OVA as described above. The obtained cells were stained with 2 μM of CFSE (Life Technologies Corporation, Carlsbad, CA), and were transferred to WT mice (Supporting Information Figure 1A and B).
Cell preparation
Thymus, LN, and spleen were collected from 4 to 8-week old mice to obtain single cell suspensions by mechanical digestion. PBMCs were isolated from whole blood by using Histopaque-1083 reagent (Sigma Aldrich). The cells in the air pouch were collected as described above.
Spelenectomy and thymectomy
The spleen was exposed by an oblique incision, in the left upper abdominal quadrant while the animal was kept under anesthesia with Avertin (2, 2, 2-Tribromoethanol) (Sigma Aldrich). After the splenic arteries and venous vessels were cauterized to minimize blood loss, the spleen was removed. The thymus was mechanically removed through an incision in the neck and thoracic wall extending to the level of the second rib, while mice were kept under anesthesia with Avertin. Sham-treated animals received identical manipulations without actual spleen and thymus removal prior to wound suturing. Hamano 17 Mice were subcutaneously immunized with 200 μg of OVA protein in 200 μl of the emulsion consisting of an equal volume of PBS and complete Freund's adjuvant (CFA) (Sigma Aldrich). Ten days after the immunization, 100 μg of heat aggregated OVA in 50 μl of PBS was injected into the footpad. 24 h after the footpad injection, footpad thickness was measured and the intensity of inflammation was histologically evaluated.
DTH
Preparation of BM chimeric mice
BM cells were obtained from DO11.10 and WT mice, and the resultant cells were mixed at the indicated ratio. After WT recipient mice were lethally irradiated (8 Gy), they received 1×10 7 BM cells intravenously. The experiments were conducted on the obtained BM chimeric mice more than three weeks after transplantation.
In vivo transfection of tRANTES
cDNA encoding mouse tRANTES (its nucleotide sequence described in Supporting Information Figure 6 ) was subcloned into the pLIVE expression plasmid vector (Mirus, Madison, WI). 10 g of the resultant or empty pLIVE expression plasmid vector was injected into mice by using TransIT®-EE Delivery Solution (Mirus) according to the manufacturer's instructions, because this gene delivery system can sustain serum tRNATES levels at higher than 1 ng/ml for 2 months after the injection (our unpublished data).
Immunohistochemical analysis
Mouse footpads were cut off and fixed in fixating agent, Yufix (Sakura Finetec Japan, Tokyo, Japan). After subsequent decalcification with formic acid (Nacalai Tesque, Kyoto, Japan), the samples were embedded with paraffin and sliced at 3 μm thickness.
For Ag retrieval, the deparaffinized slides were autoclaved in 10 mmol/L citrate buffer (pH 6.0) for 10 min at 120 o C. After blocking with a protein block serum-free solution Hamano 18 (DAKO, Carpinteria, CA), anti-Foxp3 Ab (FJK-26s) was added to the tissue sections and incubated overnight in a humidified box at 4 o C. Immune complexes were then detected using the CSA systems (DAKO) followed by staining with hematoxylin.
Determination of chemokine concentrations
Concentrations of MCP-1/CCL2, TARC/CCL17, MDC/CCL22, RANTES/CCL5 and SDF-1/CXCL12 in the air pouch fluid were determined by Quantikine ELISA kit (R&D systems) according to the manufacturer's instructions. 
Legends to Supplemental Figures
S1. Nucleotide sequence of tRANTES
The inserted tRANTES nucleotide sequence is shown. Blue and red sequence encodes RANTES signal peptide and 9-68 RANTES (mature peptide), respectively.
S2. Gating strategy of Tregs and Teffs
Cells were stained by KJ1-26 and 
S9. Chimerism of DO11.10 TCR expressing T cells in BM chimera
Peripheral blood was obtained from BM chimera to determine the proportion of 
S11. Effects of CCR4 blockade on antigen-induced immune reaction in DTH
BM chimeric mice were treated with the protocol shown in Figure 4A . Anti-CCL17
was intravenously injected 1 hr before OVA injection to footpad. As a control, rat-IgG was injected. Paw thickness were determined on 5 individual animals. The changes in thickness (Δmm) were calculated by subtracting the original thickness from the
